ManageMR vs COAPT Risk Score
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ManageMR
This medical app offers personalized referral and treatment guidance for mitral regurgitation patients. It analyzes echo assessment parameters to determine MR severity, etiology, and recommend appropriate interventions like valve repair or replacement.
- Personalized referral advice
- Treatment recommendations
- MR severity and etiology analysis
- Mitral valve repair vs. replacement feasibility
- Echo assessment parameter entry
Read full descriptionHide full description
This clinical decision support app provides clinicians with personalized referral and treatment advice for diagnosed mitral regurgitation patients by verifying the severity and etiology of the MR. • Enter patient parameters from an echo assessment. • Review customized advice on - Probable severity and etiology of a patient’s MR - Need for referral - Feasibility of mitral valve repair vs. replacement for the patient Content in this app is derived from the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation. The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.
COAPT Risk Score
This medical tool calculates a 2-year risk score for death and/or heart failure hospitalization in patients with specific heart conditions. It combines clinical and echocardiographic data to aid in shared decision-making regarding treatment options.
- Risk prediction for death and heart failure hospitalization
- Calculates 2-year risk score
- Combines clinical and echocardiographic variables
- Supports shared decision-making
- Educational tool for medical professionals
- Based on COAPT trial data
Read full descriptionHide full description
For educational purposes and for use by medical professionals only. For patients with severe functional mitral regurgitation and symptomatic heart failure (left ventricular ejection fraction between 20-50%) despite best medical therapy. The COAPT Risk Score is a simple risk prediction tool created by combining clinical and echocardiographic variables in patients with heart failure (HF) and moderate-to-severe or severe functional mitral regurgitation (FMR) who remain symptomatic despite maximally tolerated guideline directed medical therapy (GDMT). The COAPT Risk Score provides valuable prognostic information regarding the 2-year risk of death and/or heart failure hospitalization (HFH). The score is derived from the COAPT trial population of patients with HF and moderate-to-severe or severe FMR randomized to treatment with either transcatheter edge-to-edge repair (TEER) with MitraClip plus GDMT or GDMT alone. We can incorporate TEER in the risk score and provide updated 2-year risk of death and/or HFH which can serve as a valuable shared decision-making tool for patients and physicians as well as heart teams while deciding about TEER. Created by a team of subject-matter experts including: the director of The Mount Sinai Hospital cardiac cath lab Dr. Kini, Director of Clinical and Interventional Cardiology at the Mount Sinai Health System Dr Sharma, the Mount Sinai Hospital Surgical Director Dr. Tang, COAPT Principal Investigator Dr. Stone, and COAPT Risk Score publication author Dr. Shah.
Screenshots
Verdict
ManageMR and COAPT Risk Score are too close to call on the numbers: across 8 compared parameters — price, rating, ratings volume and ads among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for ManageMR against 5.0 for COAPT Risk Score. Both are backed by a comparable volume of ratings — 1 and 1 respectively.
| Parameter | ManageMR | COAPT Risk Score |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) | 5.0 (1 ratings) |
| Number of ratings | 1 | 1 |
| Update frequency | Every 21 months | — |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 | 12.0 — better |
| Further details — not scored | ||
| Size | 58 MB | 28 MB |
| Age rating | 17+ | 17+ |
| Developer | American College of Cardiology | Cardiology Apps LLC |
Customer experience
ManageMR
COAPT Risk Score
In-app purchases
ManageMR
No in-app purchases
COAPT Risk Score
No in-app purchases
Questions
Is ManageMR free?
Is COAPT Risk Score free?
Which has better reviews, ManageMR or COAPT Risk Score?
Do ManageMR or COAPT Risk Score have ads?
Other comparisons















